Guido Dalbagni, MD, FACS
Dr. Guido Dalbagni is a surgeon with expertise in the treatment of urologic tumors. His primary areas of interest are bladder cancer and bladder reconstruction following surgery. He is currently heading clinical trials at Memorial Sloan-Kettering to evaluate new therapies for the treatment of high-risk superficial bladder cancer in patients who are resistant to bacillus Calmette-Guérin (BCG) therapy, the standard treatment.
Click here for more information.